| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 724QD330RD |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Integrin alpha-V/beta-1 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Scleroderma, Systemic | 2 | D012595 | ClinicalTrials |
| Lung Diseases, Interstitial | 2 | D017563 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Colorectal Neoplasms | 1 | D015179 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1105038-73-0 |
| ChEMBL | CHEMBL2109621 |
| FDA SRS | 724QD330RD |
CONTENTS